Taiwan FDA registration ebe9c50874bd4bf0f3ab7e874cd9794f
“HaemoCer” Haemostatic Powder
TW: “百歐瑟”止血粉
Taiwan·Risk Class 3·MD·BIOCER ENTWICKLUNGS-GMBH·Registered Apr 01, 2019 – Apr 01, 2024ExpiredRegistration details
- Analysis ID
- ebe9c50874bd4bf0f3ab7e874cd9794f
- License Form
- Ministry of Health Medical Device Import No. 032360
- Customs Code
- DHA05603236001
Company information
- Manufacturer
- BIOCER ENTWICKLUNGS-GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- Health Land Inc.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- I General and plastic surgical devices
- Product Type (Level 2)
- I4490 Absorbable hemostatic agents and dressings
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Apr 01, 2019
- Expiry Date
- Apr 01, 2024
About this record
Access comprehensive regulatory information for “HaemoCer” Haemostatic Powder in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number ebe9c50874bd4bf0f3ab7e874cd9794f and manufactured by BIOCER ENTWICKLUNGS-GMBH. The authorized representative in Taiwan is Health Land Inc..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices